RTA Laboratuvarlari Biyolojik Urunler Ilac ve Makine Sanayi Ticaret Stock

Equities

RTALB

TRERTAL00018

Pharmaceuticals

Market Closed - Borsa Istanbul 11:09:29 2024-06-07 am EDT 5-day change 1st Jan Change
12.2 TRY +0.58% Intraday chart for RTA Laboratuvarlari Biyolojik Urunler Ilac ve Makine Sanayi Ticaret +7.58% -14.92%
Sales 2022 86.03M 2.66M Sales 2023 95.94M 2.97M Capitalization 1.43B 44.33M
Net income 2022 281M 8.69M Net income 2023 - EV / Sales 2022 14.2 x
Net cash position 2022 79.61M 2.46M Net cash position 2023 56.35M 1.74M EV / Sales 2023 14.4 x
P/E ratio 2022
4.62 x
P/E ratio 2023
-
Employees 54
Yield 2022 *
-
Yield 2023
-
Free-Float 80.67%
More Fundamentals * Assessed data
Dynamic Chart
RTA Laboratuvarlari Biyolojik Urunler Ilac ve Makine Sanayi Ticaret A.S. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
RTA Laboratuvarlari Biyolojik Urunler Ilac ve Makine Sanayi Ticaret A.S. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
RTA Laboratuvarlari Biyolojik Urunler Ilac ve Makine Sanayi Ticaret A.S. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023 CI
RTA Laboratuvarlari Biyolojik Urunler Ilac ve Makine Sanayi Ticaret A.S. Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
RTA Laboratuvarlari Biyolojik Urunler Ilac ve Makine Sanayi Ticaret A.S. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022 CI
RTA Laboratuvarlari Biyolojik Urunler Ilac ve Makine Sanayi Ticaret A.S.(IBSE:RTALB) dropped from S&P Global BMI Index CI
RTA Laboratuvarlari Biyolojik Urunler Ilac ve Makine Sanayi Ticaret A.S. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022 CI
RTA Laboratuvarlari Biyolojik Urunler Ilac ve Makine Sanayi Ticaret A.S. Reports Earnings Results for the First Quarter Ended March 31, 2022 CI
RTA Laboratuvarlari Biyolojik Urunler Ilac ve Makine Sanayi Ticaret A.S. Reports Earnings Results for the Full Year Ended December 31, 2021 CI
RTA Laboratuvarlari Biyolojik Urunler Ilac ve Makine Sanayi Ticaret A.S. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021 CI
Rta Laboratuvarlari Biyolojik Urunler Ilac Ve Makine Sanayi Ticaret A.S. Reports Earnings Results for the Second Quarter Ended June 30, 2021 CI
Rta Laboratuvarlari Biyolojik Urunler Ilac Ve Makine Sanayi Ticaret A.S. Reports Earnings Results for the First Quarter Ended March 31, 2021 CI
Rta Laboratuvarlari Biyolojik Urunler Ilac Ve Makine Sanayi Ticaret A.S. Reports Earnings Results for the Full Year Ended December 31, 2020 CI
Rta Laboratuvarlari Biyolojik Urunler Ilac Ve Makine Sanayi Ticaret A.S. Reports Earnings Results for the Third Quarter Ended September 30, 2020 CI
RTA Laboratuvarlari Biyolojik Urunler Ilac ve Makine Sanayi Ticaret A.S.(IBSE:RTALB) added to S&P Global BMI Index CI
More news
1 day+0.58%
1 week+7.58%
Current month+7.58%
1 month-3.79%
3 months-10.75%
6 months-23.51%
Current year-14.92%
More quotes
1 week
11.14
Extreme 11.14
13.42
1 month
11.14
Extreme 11.14
13.57
Current year
11.11
Extreme 11.11
17.35
1 year
7.75
Extreme 7.75
21.20
3 years
5.77
Extreme 5.7666
21.20
5 years
0.49
Extreme 0.4899
27.80
10 years
0.49
Extreme 0.4899
27.80
More quotes
Managers TitleAgeSince
Chief Executive Officer - 21-07-12
Investor Relations Contact - -
Members of the board TitleAgeSince
Chairman 53 18-09-26
Director/Board Member 55 18-09-26
Chief Executive Officer - 21-07-12
More insiders
Date Price Change Volume
24-06-07 12.2 +0.58% 7,326,701
24-06-06 12.13 -3.27% 10,747,880
24-06-05 12.54 +10.00% 12,269,540
24-06-04 11.4 +1.15% 1,462,523
24-06-03 11.27 -0.62% 1,254,739

Delayed Quote Borsa Istanbul, June 07, 2024 at 11:09 am EDT

More quotes
RTA Laboratuvarlari Biyolojik Urunler Ilac ve Makine Sanayi Ticaret AS is a Turkey-based company engaged in the research, development and production of in vitro diagnostics. Its diagnostic products include: Clinical Microbiology, such as chromogenic media, culture media in petri dishes, tubes and bottles, rodac petri surcheck, and tuberculosis diagnosis products; ELISA Kits, such as HBsAg ELISA Kit; Molecular Diagnostics, such as nucleic acid isolation kits, real-time PCR instruments, real-time PCR kits and RTA VOLTRAN voral detection system, as well as other tests. Its Research includes: dehydrated culture media, such as dehydrated chromogenic culture media; nucleic acid isolation kits and real-time PCR.
More about the company